Showing results (161-170 of 1,273) with videos related to

Sort By:
Pageof 128
Clinical Colorectal Cancer|December 17, 2005
FOLFOX alternated with FOLFIRI as first-line chemotherapy for metastatic colorectal cancerJorge Aparicio, Carlos Fernandez-Martos, Jose M Vincent, et al.
Clinical Colorectal Cancer|December 17, 2005
Contemporary applications of transanal endoscopic microsurgery: technical innovations and limitationsJose G Guillem, David B Chessin, Seung-Yong Jeong, et al.
Clinical Colorectal Cancer|December 22, 2005
Management of colorectal cancer in pregnancy: a multimodality approachM Wasif Saif
Clinical Colorectal Cancer|December 13, 2005
Epidermal growth factor receptor-negative colorectal cancer: is there truly such an entity?Leonard Saltz
Clinical Colorectal Cancer|January 13, 2015
A review of the evolution of systemic chemotherapy in the management of colorectal cancerBengt Gustavsson, Göran Carlsson, David Machover, et al.
Clinical Colorectal Cancer|January 17, 2015
A phase Ib study of the VEGF receptor tyrosine kinase inhibitor tivozanib and modified FOLFOX-6 in patients with advanced gastrointestinal malignanciesCorina N Oldenhuis, Walter J Loos, Brooke Esteves, et al.
Clinical Colorectal Cancer|June 7, 2016
Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course RadiotherapyJonathan M Loree, Hagen F Kennecke, Daniel J Renouf, et al.
Clinical Colorectal Cancer|August 10, 2017
Clinical Analysis of Primary Colorectal Signet-Ring Cell CarcinomaZhengZi Liang, DengGuo Yan, GuoSheng Li, et al.
Clinical Colorectal Cancer|September 20, 2015
Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center SeriesJavier Sastre, Juan Jose Serrano, Cristina Fernández, et al.
Clinical Colorectal Cancer|November 4, 2017
Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation StatusSalvatore Siena, Fernando Rivera, Julien Taieb, et al.
Pageof 128